Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07260864 · ClinicalTrials.gov registry record · NA

Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With Fibromyalgia

A NA study, sponsored by University of Rochester.

Not yet
Registry status
NA
Development phase
20
Enrollment target

NCT07260864: Clinical Trial NA study, sponsored by University of Rochester.

NCT07260864 is a NA study that has not yet begun recruiting, run by University of Rochester. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07260864, a NA study, has not yet begun recruiting, sponsored by University of Rochester.

NOT YET RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The first goal of this study is to see how brain activity changes in people with fibromyalgia after they get a treatment called rTMS (repetitive transcranial magnetic stimulation). Researchers are looking at how the parts of the brain that control movement (called motor cortices) respond to this treatment. The second goal is to find out if the changes in brain activity are different between the right and left sides of the brain, depending on which side gets the treatment.

Primary Outcome

Resting-state fMRI will be used to derive connectopy embeddings of the primary motor cortex (M1). Connectopy embeddings from the stimulated side will be extracted from significant baseline-defined clusters. A single value per participant is derived by averaging the embedding values within this cluster. Higher scores indicate increased similarity to healthy reference profiles (improved functional connectivity), while lower scores indicate deviation from healthy reference patterns (reduced functio

Interventions

  • OTHER rTMS

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-12-30
Est. Completion 2026-09-30
Phase NA
University of Rochester

636 total trials

What is known before NCT07260864 opens enrollment

NCT07260864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which rTMS is the first listed.

NCT07260864 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07260864 about?

NCT07260864 is a clinical study titled "Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With Fibromyalgia". The first goal of this study is to see how brain activity changes in people with fibromyalgia after they get a treatment called rTMS (repetitive transcranial magnetic stimulation). Researchers are looking at how the parts of the brain that control movement (called motor cortices) respond to this tre...

What is the current status of trial NCT07260864?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-12-30. Estimated completion is 2026-09-30.

What interventions are being tested in trial NCT07260864?

The interventions under investigation include: rTMS (OTHER).

Who is sponsoring clinical trial NCT07260864?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07260864's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07260864, the US trial registry maintained by the National Library of Medicine. NCT07260864 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.